CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX)
CUSIP: 230770109
Q1 2019 13F Holders as of 31 Mar 2019
- Type / Class
- Equity / Common stock
- Shares outstanding
- 15,075,924
- Total 13F shares
- 4,924,596
- Share change
- -60,030
- Total reported value
- $28,610,000
- Price per share
- $5.81
- Number of holders
- 22
- Value change
- -$352,915
- Number of buys
- 6
- Number of sells
- 10
Quarterly Holders Quick Answers
What is CUSIP 230770109?
CUSIP 230770109 identifies CPIX - CUMBERLAND PHARMACEUTICALS INC - Common stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 230770109:
Top shareholders of CPIX - CUMBERLAND PHARMACEUTICALS INC - Common stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Stonepine Capital Management, LLC |
13F
|
Company |
8.7%
|
1,313,429
|
$7,920,000 | — | 31 Dec 2018 | |
| ARIEL INVESTMENTS, LLC |
13F
|
Company |
7.8%
|
1,179,803
|
$7,114,000 | — | 31 Dec 2018 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
5.8%
|
880,248
|
$5,546,000 | — | 31 Dec 2018 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2.5%
|
381,374
|
$2,300,000 | — | 31 Dec 2018 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.1%
|
314,024
|
$1,979,000 | — | 31 Dec 2018 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2%
|
306,901
|
$1,851,000 | — | 31 Dec 2018 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
200,400
|
$1,263,000 | — | 31 Dec 2018 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.65%
|
97,733
|
$588,000 | — | 31 Dec 2018 | |
| BARD ASSOCIATES INC |
13F
|
Company |
0.52%
|
78,115
|
$492,000 | — | 31 Dec 2018 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.36%
|
53,800
|
$339,000 | — | 31 Dec 2018 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.32%
|
48,610
|
$306,000 | — | 31 Dec 2018 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.18%
|
27,227
|
$164,000 | — | 31 Dec 2018 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.13%
|
20,338
|
$123,000 | — | 31 Dec 2018 | |
| MORGAN STANLEY |
13F
|
Company |
0.12%
|
17,479
|
$105,000 | — | 31 Dec 2018 | |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC |
13F
|
Company |
0.11%
|
16,626
|
$105,000 | — | 31 Dec 2018 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.08%
|
12,127
|
$72,000 | — | 31 Dec 2018 | |
| DELTA ASSET MANAGEMENT LLC/TN |
13F
|
Company |
0.08%
|
12,000
|
$72,000 | — | 31 Dec 2018 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.07%
|
10,000
|
$60,000 | — | 31 Dec 2018 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.03%
|
5,198
|
$31,000 | — | 31 Dec 2018 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
3,711
|
$22,000 | — | 31 Dec 2018 | |
| Oakworth Capital, Inc. |
13F
|
Company |
0.02%
|
3,052
|
$18,000 | — | 31 Dec 2018 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.01%
|
2,094
|
$13,000 | — | 31 Dec 2018 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.01%
|
1,573
|
$4,000 | — | 31 Dec 2018 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
269
|
$2,000 | — | 31 Dec 2018 | |
| LADENBURG THALMANN FINANCIAL SERVICES INC. |
13F
|
Company |
0%
|
237
|
$1,000 | — | 31 Dec 2018 |
Institutional Holders of CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX) as of Q1 2019
As of 31 Mar 2019,
CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,924,596 shares.
The largest 10 holders included
Stonepine Capital Management, LLC, ARIEL INVESTMENTS, LLC, DIMENSIONAL FUND ADVISORS LP, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, BlackRock Inc., BRIDGEWAY CAPITAL MANAGEMENT INC, ACADIAN ASSET MANAGEMENT LLC, BARD ASSOCIATES INC, and CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM.
This page lists
22
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2019 vs Q4 2018 Across Filers
Q4 2018 holders
22
Q1 2019 holders
22
Holder diff
0
| Investor | Q4 2018 Shares | Q1 2019 Shares | Share Diff | Share Chg % | Q4 2018 Value $ | Q1 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.